Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 274

    1.

    Diabetes mellitus and gastric emptying: questions and issues in clinical practice.

    Samsom M, Bharucha A, Gerich JE, Herrmann K, Limmer J, Linke R, Maggs D, Schirra J, Vella A, Wörle HJ, Göke B.

    Diabetes Metab Res Rev. 2009 Sep;25(6):502-14.PMID: 19610128 [PubMed - in process]Related articles

    2.

    Is a history of gestational diabetes related to risk factors for coronary heart disease?

    King KB, Gerich JE, Guzick DS, King KU, McDermott MP.

    Res Nurs Health. 2009 Jun;32(3):298-306.PMID: 19274765 [PubMed - indexed for MEDLINE]Related articles

    3.

    Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide.

    Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Göke B, Schirra J.

    Diabetes Care. 2008 Dec;31(12):2325-31.PMID: 19033417 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors.

    Gerich JE.

    Clin Cornerstone. 2007;8(3):53-68. Review.PMID: 18452842 [PubMed - indexed for MEDLINE]Related articles

    5.

    Glycemic control in the metabolic syndrome and implications in preventing cardiovascular disease.

    Gerich JE.

    Metab Syndr Relat Disord. 2006 Winter;4(4):315-27.PMID: 18370749 [PubMed - in process]Related articles

    6.

    Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance.

    Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, Mitrakou A, Pimenta W, Gerich JE.

    Diabetes Care. 2008 Mar;31(3):539-43. Epub 2007 Dec 14.PMID: 18083793 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.

    Schwarz SL, Gerich JE, Marcellari A, Jean-Louis L, Purkayastha D, Baron MA.

    Diabetes Obes Metab. 2008 Aug;10(8):652-60. Epub 2007 Oct 15.PMID: 17941876 [PubMed - indexed for MEDLINE]Related articles

    8.

    The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.

    Gerich JE, Odawara M, Terauchi Y.

    Curr Med Res Opin. 2007 Aug;23(8):1791-8.PMID: 17610805 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease.

    Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB.

    J Thromb Haemost. 2007 May;5(5):942-9.PMID: 17461928 [PubMed - indexed for MEDLINE]Related articles

    10.

    The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.

    Dunning BE, Gerich JE.

    Endocr Rev. 2007 May;28(3):253-83. Epub 2007 Apr 4. Review.PMID: 17409288 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

    Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

    Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.PMID: 17240473 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk.

    Gerich JE.

    Diabetes Educ. 2006 Jul-Aug;32(4):513-4, 520-2.PMID: 16873589 [PubMed - indexed for MEDLINE]Related articles

    13.

    Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.

    Israelian Z, Szoke E, Woerle J, Bokhari S, Schorr M, Schwenke DC, Cryer PE, Gerich JE, Meyer C.

    Metabolism. 2006 May;55(5):593-8.PMID: 16631434 [PubMed - indexed for MEDLINE]Related articles

    14.

    Postprandial hyperglycemia and cardiovascular disease.

    Gerich JE.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:47-51. Review.PMID: 16627380 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.

    Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE.

    Metabolism. 2006 Jan;55(1):78-83.PMID: 16324923 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.

    Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C.

    Diabetes Care. 2005 Nov;28(11):2691-6.PMID: 16249541 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The importance of tight glycemic control.

    Gerich JE.

    Am J Med. 2005 Sep;118(Suppl 9A):7S-11S. Review.PMID: 16224937 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

    Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE.

    Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E67-E77. Epub 2005 Aug 16.PMID: 16105859 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

    Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

    Diabetes Care. 2005 Jul;28(7):1630-5.PMID: 15983312 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

    Szoke E, Gerich JE.

    Compr Ther. 2005 Summer;31(2):106-12. Review.PMID: 15901939 [PubMed - indexed for MEDLINE]Related articles

    21.

    Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.

    Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C.

    Diabetes Care. 2005 May;28(5):1124-31.PMID: 15855577 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Advances in diabetes for the millennium: understanding insulin resistance.

    Gerich JE, Dailey G.

    MedGenMed. 2004 Aug 26;6(3 Suppl):11. Review.PMID: 15647716 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.

    Fonseca VA, Kelley DE, Cefalu W, Baron MA, Purkayastha D, Nestler JE, Hsia S, Gerich JE.

    Metabolism. 2004 Oct;53(10):1331-5. Erratum in: Metabolism. 2005 May;54(5):698. PMID: 15375790 [PubMed - indexed for MEDLINE]Related articles

    24.

    Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.

    Meyer C, Woerle HJ, Dostou JM, Welle SL, Gerich JE.

    Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1049-56. Epub 2004 Aug 10.PMID: 15304374 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

    Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE.

    Arch Intern Med. 2004 Aug 9-23;164(15):1627-32.PMID: 15302632 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Insulin glargine: long-acting basal insulin analog for improved metabolic control.

    Gerich JE.

    Curr Med Res Opin. 2004 Jan;20(1):31-7. Review.PMID: 14741069 [PubMed - indexed for MEDLINE]Related articles

    27.

    Clinical significance, pathogenesis, and management of postprandial hyperglycemia.

    Gerich JE.

    Arch Intern Med. 2003 Jun 9;163(11):1306-16. Review.PMID: 12796066 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity.

    Woerle HJ, Meyer C, Popa EM, Cryer PE, Gerich JE.

    Diabetes. 2003 Jun;52(6):1386-92.PMID: 12765948 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.

    Gerich JE.

    Mayo Clin Proc. 2003 Apr;78(4):447-56. Review.PMID: 12683697 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.

    Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE.

    Diabetes. 2003 Apr;52(4):918-25.PMID: 12663461 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Role of the kidney in hyperglycemia in type 2 diabetes.

    Meyer C, Gerich JE.

    Curr Diab Rep. 2002 Jun;2(3):237-41. Review.PMID: 12643179 [PubMed - indexed for MEDLINE]Related articles

    32.

    Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients.

    Pimenta WP, Santos ML, Cruz NS, Aragon FF, Padovani CR, Gerich JE.

    Braz J Med Biol Res. 2003 Mar;36(3):301-8. Epub 2003 Mar 7.PMID: 12640493 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Hepatorenal glucose reciprocity in physiologic and pathologic conditions.

    Gerich JE.

    Diabetes Nutr Metab. 2002 Oct;15(5):298-302; discussion 302-3. Review. No abstract available. PMID: 12625473 [PubMed - indexed for MEDLINE]Related articles

    34.

    Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.

    Pimenta WP, Santos ML, Cruz NS, Aragon FF, Padovani CR, Gerich JE.

    Diabetes Metab. 2002 Dec;28(6 Pt 1):468-76.PMID: 12522327 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Pathways for glucose disposal after meal ingestion in humans.

    Woerle HJ, Meyer C, Dostou JM, Gosmanov NR, Islam N, Popa E, Wittlin SD, Welle SL, Gerich JE.

    Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E716-25. Epub 2002 Dec 10.PMID: 12475753 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Novel insulins: expanding options in diabetes management.

    Gerich JE.

    Am J Med. 2002 Sep;113(4):308-16. Review.PMID: 12361817 [PubMed - indexed for MEDLINE]Related articles

    37.

    Autoregulation of endogenous glucose production during hyperglucagonemia.

    Toft I, Gerich JE, Jenssen T.

    Metabolism. 2002 Sep;51(9):1128-34.PMID: 12200756 [PubMed - indexed for MEDLINE]Related articles

    38.

    Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology.

    Gerich JE.

    Eur J Clin Invest. 2002 Jun;32 Suppl 3:46-53. Review.PMID: 12028374 [PubMed - indexed for MEDLINE]Related articles

    39.

    Disturbances in beta-cell function in impaired fasting glycemia.

    van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE.

    Diabetes. 2002 Feb;51 Suppl 1:S265-70.PMID: 11815491 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.
    41.

    Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis.

    Meyer C, Dostou JM, Welle SL, Gerich JE.

    Am J Physiol Endocrinol Metab. 2002 Feb;282(2):E419-27.PMID: 11788375 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Matching treatment to pathophysiology in type 2 diabetes.

    Gerich JE.

    Clin Ther. 2001 May;23(5):646-59; discussion 645. Review.PMID: 11394726 [PubMed - indexed for MEDLINE]Related articles

    43.

    Measurements of renal glucose release.

    Gerich JE.

    Diabetes. 2001 Apr;50(4):905. No abstract available. PMID: 11289061 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Physiology of glucose homeostasis.

    Gerich JE.

    Diabetes Obes Metab. 2000 Dec;2(6):345-50. Review. No abstract available. PMID: 11225963 [PubMed - indexed for MEDLINE]Related articles

    45.

    Is insulin resistance the principal cause of type 2 diabetes?

    Gerich JE.

    Diabetes Obes Metab. 1999 Sep;1(5):257-63. Review.PMID: 11225637 [PubMed - indexed for MEDLINE]Related articles

    46.

    Renal gluconeogenesis: its importance in human glucose homeostasis.

    Gerich JE, Meyer C, Woerle HJ, Stumvoll M.

    Diabetes Care. 2001 Feb;24(2):382-91. Review.PMID: 11213896 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Hypoglycaemia and counterregulation in type 2 diabetes.

    Gerich JE.

    Lancet. 2000 Dec 9;356(9246):1946-7. No abstract available. PMID: 11130519 [PubMed - indexed for MEDLINE]Related articles

    48.

    Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia.

    van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE.

    Metabolism. 2000 Oct;49(10):1318-25.PMID: 11079822 [PubMed - indexed for MEDLINE]Related articles

    49.

    Addressing the insulin secretion defect: a logical first-line approach.

    Gerich JE.

    Metabolism. 2000 Oct;49(10 Suppl 2):12-6. Review.PMID: 11078470 [PubMed - indexed for MEDLINE]Related articles

    50.

    Insulin resistance is not necessarily an essential component of type 2 diabetes.

    Gerich JE.

    J Clin Endocrinol Metab. 2000 Jun;85(6):2113-5. Review. No abstract available. PMID: 10852436 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...